search
Back to results

Bexagliflozin Efficacy and Safety Trial (BEST)

Primary Purpose

Type 2 Diabetes Mellitus

Status
Completed
Phase
Phase 3
Locations
International
Study Type
Interventional
Intervention
Bexagliflozin
Placebo
Sponsored by
Theracos
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Type 2 Diabetes Mellitus

Eligibility Criteria

40 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Subjects with a diagnosis of T2DM
  • Subjects who have had a stable treatment regimen for T2DM for the past 3 months
  • Subjects who present with at least one of the following 3 histories:

Group 1: A history of atherosclerotic vascular disease Group 2: A history of heart failure Group 3: Age ≥ 55 years with diabetes for ≥ 10 years, uncontrolled hypertension, currently smoking, reduced kidney function, or cholesterol problems

Exclusion Criteria:

  • Diagnosis of type 1 diabetes mellitus or maturity-onset/diabetes of the young
  • History of genitourinary tract infections
  • Evidence of abnormal liver function
  • History of MI, stroke or hospitalization for heart failure in the past 3 months
  • Prior kidney transplant or evidence of kidney problems
  • Prior or planned pace maker implantation
  • Pregnant or nursing

Sites / Locations

  • Research Site 1090
  • Research Site 1041
  • Research Site 1073
  • Research Site 1076
  • Research Site 1078
  • Research Site 1089
  • Research Site 1058
  • Research Site 1051
  • Research Site 1004
  • Research Site 1068
  • Research Site 1077
  • Research Site 1218
  • Research Site 1092
  • Research Site 1216
  • Research Site 1083
  • Research Site 1057
  • Research Site 1059
  • Research Site 1050
  • Research Site 1099
  • Research Site 1066
  • Research Site 1072
  • Research Site 1082
  • Research Site 1258
  • Research Site 1043
  • Research Site 1071
  • Research Site 1086
  • Research Site 1224
  • Research Site 1228
  • Research Site 1221
  • Research Site 1079
  • Research Site 1223
  • Research Site 1217
  • Research Site 1254
  • Research Site 1054
  • Research Site 1060
  • Research Site 1252
  • Research Site 1052
  • Research Site 1263
  • Research Site 1080
  • Research Site 1219
  • Research Site 1044
  • Research Site 1264
  • Research Site 1220
  • Research Site 1049
  • Research Site 1085
  • Research Site 1074
  • Research Site 1056
  • Research Site 1229
  • Research Site 1064
  • Research Site 1075
  • Research Site 1266
  • Research Site 1055
  • Research Site 1265
  • Research Site 1046
  • Research Site 1260
  • Research Site 1042
  • Research Site 1225
  • Research Site 1259
  • Research Site 1048
  • Research Site 1070
  • Research Site 1222
  • Research Site 1081
  • Research Site 1226
  • Research Site 1053
  • Research Site 1063
  • Research Site 1230
  • Research Site 5013
  • Research Site 5015
  • Research Site 5012
  • Research Site 5023
  • Research Site 5016
  • Research Site 5005
  • Research Site 5022
  • Research Site 5014
  • Research Site 5008
  • Research Site 5007
  • Research Site 5009
  • Research Site 5006
  • Research Site 3116
  • Research Site 3106
  • Research Site 3107
  • Research Site 3118
  • Research Site 3109
  • Research Site 3114
  • Research Site 3103
  • Research Site 3110
  • Research Site 3102
  • Research Site 3105
  • Research Site 3113
  • Research Site 3104
  • Research Site 3111
  • Research Site 3112
  • Research Site 3115
  • Research Site 6104
  • Research Site 6103
  • Research Site 6105
  • Research Site 7007
  • Research Site 7001
  • Research Site 7004
  • Research Site 7005
  • Research Site 7006
  • Research Site 7002
  • Research Site 7008
  • Research Site 2015
  • Research Site 2013
  • Research Site 2008
  • Research Site 2012
  • Research Site 2011
  • Research Site 2009
  • Research Site 2014
  • Research Site 2016
  • Research Site 2010
  • Research Site 5110
  • Research Site 5113
  • Research Site 5101
  • Research Site 5112
  • Research Site 5102
  • Research Site 5106
  • Research Site 5103
  • Research Site 7122
  • Research Site 7113
  • Research Site 7119
  • Research Site 7109
  • Research Site 7115
  • Research Site 7106
  • Research Site 7121
  • Research Site 7111
  • Research Site 7104
  • Research Site 7135
  • Research Site 7120
  • Research Site 7108
  • Research Site 7118
  • Research Site 7107
  • Research Site 7105
  • Research Site 7112
  • Research Site 7123
  • Research Site 7117
  • Research Site 7116
  • Research Site 9309
  • Research Site 9303
  • Research Site 9315
  • Research Site 9314
  • Research Site 9318
  • Research Site 9301
  • Research Site 9310
  • Research Site 9304
  • Research Site 9307
  • Research Site 9311
  • Research Site 9312
  • Research Site 9302
  • Research Site 8001
  • Research Site 8002
  • Research Site 8006
  • Research Site 8005
  • Research Site 8007
  • Research Site 8004
  • Research Site 8003

Arms of the Study

Arm 1

Arm 2

Arm Type

Active Comparator

Placebo Comparator

Arm Label

Bexagliflozin tablets, 20 mg

Placebo tablets

Arm Description

Each subject will receive bexagliflozin 20 mg once daily for the duration of the study.

Each subject will receive placebo (inactive tablet) once daily for the duration of the study.

Outcomes

Primary Outcome Measures

Change in HbA1c From Baseline to Week 24
The primary efficacy objective of this trial is to evaluate the placebo-adjusted change in HbA1c from baseline after 24 weeks of treatment with 20 mg bexagliflozin tablets in type 2 diabetic subjects with increased risk of cardiovascular adverse events.

Secondary Outcome Measures

Change From Baseline in HbA1c at Week 24 for Subjects Who Have Been Prescribed Insulin
To evaluate the effect of 20 mg bexagliflozin on the change in HbA1c from baseline to week 24 in randomized subjects who have been prescribed insulin to control their diabetes
Change in Body Weight From Baseline to Week 48
To evaluate the effect of 20 mg bexagliflozin on the change in body weight from baseline to week 48 in randomized subjects with a BMI ≥ 25 kg/m2 compared to placebo
Change in Systolic Blood Pressure From Baseline to Week 24 in Subjects Hypertensive at Baseline
To evaluate the effect of 20 mg bexagliflozin on the change in systolic blood pressure (SBP) from baseline to week 24 in subjects with baseline systolic blood pressure ≥ 140 mmHg compared to placebo

Full Information

First Posted
September 22, 2015
Last Updated
July 13, 2021
Sponsor
Theracos
search

1. Study Identification

Unique Protocol Identification Number
NCT02558296
Brief Title
Bexagliflozin Efficacy and Safety Trial
Acronym
BEST
Official Title
A Double Blind Placebo Controlled Study to Evaluate the Effects of Bexagliflozin on Hemoglobin A1c in Patients With Type 2 Diabetes and Increased Risk of Cardiovascular Adverse Events
Study Type
Interventional

2. Study Status

Record Verification Date
July 2021
Overall Recruitment Status
Completed
Study Start Date
October 2015 (Actual)
Primary Completion Date
August 2018 (Actual)
Study Completion Date
October 23, 2019 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Theracos

4. Oversight

Data Monitoring Committee
Yes

5. Study Description

Brief Summary
The purpose of this study is to investigate the effect of bexagliflozin in lowering hemoglobin A1c (HbA1c) levels in patients with type 2 diabetes mellitus (T2DM) and increased risk of cardiovascular adverse events. The data from this study will be combined with the data from other bexagliflozin studies in a meta-analysis of CV safety outcomes.
Detailed Description
Approximately 130 investigative sites globally are planned to participate in this study. An estimated 1650 subjects with inadequately controlled T2DM and an elevated risk of cardiovascular adverse events will be randomized to bexagliflozin tablets, 20 mg, or placebo in a ratio of 2:1 in addition to the background anti-diabetic medications. The study is an event-driven trial. The treatment period will end when the last randomized subject has completed at least 52 weeks of treatment and a total of at least 134 subjects have experienced a cardiac event.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Type 2 Diabetes Mellitus

7. Study Design

Primary Purpose
Treatment
Study Phase
Phase 3
Interventional Study Model
Parallel Assignment
Masking
ParticipantCare ProviderInvestigatorOutcomes Assessor
Allocation
Randomized
Enrollment
1700 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Bexagliflozin tablets, 20 mg
Arm Type
Active Comparator
Arm Description
Each subject will receive bexagliflozin 20 mg once daily for the duration of the study.
Arm Title
Placebo tablets
Arm Type
Placebo Comparator
Arm Description
Each subject will receive placebo (inactive tablet) once daily for the duration of the study.
Intervention Type
Drug
Intervention Name(s)
Bexagliflozin
Other Intervention Name(s)
EGT0001442, EGT0001474
Intervention Description
20 mg, tablet
Intervention Type
Drug
Intervention Name(s)
Placebo
Intervention Description
20 mg tablet to match active comparator
Primary Outcome Measure Information:
Title
Change in HbA1c From Baseline to Week 24
Description
The primary efficacy objective of this trial is to evaluate the placebo-adjusted change in HbA1c from baseline after 24 weeks of treatment with 20 mg bexagliflozin tablets in type 2 diabetic subjects with increased risk of cardiovascular adverse events.
Time Frame
24 weeks
Secondary Outcome Measure Information:
Title
Change From Baseline in HbA1c at Week 24 for Subjects Who Have Been Prescribed Insulin
Description
To evaluate the effect of 20 mg bexagliflozin on the change in HbA1c from baseline to week 24 in randomized subjects who have been prescribed insulin to control their diabetes
Time Frame
24 weeks
Title
Change in Body Weight From Baseline to Week 48
Description
To evaluate the effect of 20 mg bexagliflozin on the change in body weight from baseline to week 48 in randomized subjects with a BMI ≥ 25 kg/m2 compared to placebo
Time Frame
48 weeks
Title
Change in Systolic Blood Pressure From Baseline to Week 24 in Subjects Hypertensive at Baseline
Description
To evaluate the effect of 20 mg bexagliflozin on the change in systolic blood pressure (SBP) from baseline to week 24 in subjects with baseline systolic blood pressure ≥ 140 mmHg compared to placebo
Time Frame
24 weeks
Other Pre-specified Outcome Measures:
Title
Change in HbA1c From Baseline Over Time
Description
To assess the effect of 20 mg bexagliflozin treatment on the change in HbA1c from baseline versus placebo over time up to 168 weeks
Time Frame
Baseline (week 0) and weeks 6, 12, 24, 36, 48, 72, 96, 120, 144 and 168
Title
Change in Fasting Plasma Glucose Over Time
Description
To evaluate the effect of bexagliflozin treatment on the change in fasting plasma glucose (FPG) versus placebo over time up to 168 weeks
Time Frame
Baseline (week 0) and weeks 6, 12, 24, 36, 48, 72, 96, 120, 144 and 168
Title
Proportion of Subjects Requiring an Intensification of Hypoglycemic Agent and Time to First Intensification
Description
To measure the proportion of subjects requiring an intensification of hypoglycemic agent in the bexagliflozin arm versus placebo during 24 week period
Time Frame
24 week
Title
Proportion of Subjects Requiring an Intensification of Hypoglycemic Agent and Time to First Intensification
Description
To measure the proportion of subjects requiring an intensification of hypoglycemic agent in the bexagliflozin arm versus placebo during the entire study period
Time Frame
Duration of study (168 weeks)
Title
Proportion of Subjects Requiring a Relaxation of Hypoglycemic Agent
Description
To measure the proportion of subjects requiring a relaxation of hypoglycemic agent in the bexagliflozin arm versus placebo during 24 week period
Time Frame
24 weeks
Title
Proportion of Subjects Requiring a Relaxation of Hypoglycemic Agent
Description
To measure the proportion of subjects requiring a relaxation of hypoglycemic agent in the bexagliflozin arm versus placebo during the entire study
Time Frame
Duration of study (168 weeks)
Title
Proportion of Participants With Incidence of Hospitalization for Heart Failure
Description
To measure the incidence of hospitalization for heart failure among all subjects and among subjects who have a history of heart failure at baseline
Time Frame
Duration of study (168 weeks)

10. Eligibility

Sex
All
Minimum Age & Unit of Time
40 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Subjects with a diagnosis of T2DM Subjects who have had a stable treatment regimen for T2DM for the past 3 months Subjects who present with at least one of the following 3 histories: Group 1: A history of atherosclerotic vascular disease Group 2: A history of heart failure Group 3: Age ≥ 55 years with diabetes for ≥ 10 years, uncontrolled hypertension, currently smoking, reduced kidney function, or cholesterol problems Exclusion Criteria: Diagnosis of type 1 diabetes mellitus or maturity-onset/diabetes of the young History of genitourinary tract infections Evidence of abnormal liver function History of MI, stroke or hospitalization for heart failure in the past 3 months Prior kidney transplant or evidence of kidney problems Prior or planned pace maker implantation Pregnant or nursing
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
J. Paul Lock, MD
Organizational Affiliation
Theracos
Official's Role
Study Director
Facility Information:
Facility Name
Research Site 1090
City
Gilbert
State/Province
Arizona
ZIP/Postal Code
85295
Country
United States
Facility Name
Research Site 1041
City
Little Rock
State/Province
Arkansas
ZIP/Postal Code
72204
Country
United States
Facility Name
Research Site 1073
City
Azusa
State/Province
California
ZIP/Postal Code
91773
Country
United States
Facility Name
Research Site 1076
City
Concord
State/Province
California
ZIP/Postal Code
94520
Country
United States
Facility Name
Research Site 1078
City
Fresno
State/Province
California
ZIP/Postal Code
93720
Country
United States
Facility Name
Research Site 1089
City
Harbor City
State/Province
California
ZIP/Postal Code
90710
Country
United States
Facility Name
Research Site 1058
City
Lincoln
State/Province
California
ZIP/Postal Code
95821
Country
United States
Facility Name
Research Site 1051
City
Los Angeles
State/Province
California
ZIP/Postal Code
90022
Country
United States
Facility Name
Research Site 1004
City
Los Angeles
State/Province
California
ZIP/Postal Code
90057
Country
United States
Facility Name
Research Site 1068
City
Montclair
State/Province
California
ZIP/Postal Code
91763
Country
United States
Facility Name
Research Site 1077
City
Orange
State/Province
California
ZIP/Postal Code
92868
Country
United States
Facility Name
Research Site 1218
City
Denver
State/Province
Colorado
ZIP/Postal Code
80209
Country
United States
Facility Name
Research Site 1092
City
Golden
State/Province
Colorado
ZIP/Postal Code
80401
Country
United States
Facility Name
Research Site 1216
City
Norwalk
State/Province
Connecticut
ZIP/Postal Code
06851
Country
United States
Facility Name
Research Site 1083
City
Newark
State/Province
Delaware
ZIP/Postal Code
19713
Country
United States
Facility Name
Research Site 1057
City
Boca Raton
State/Province
Florida
ZIP/Postal Code
33434
Country
United States
Facility Name
Research Site 1059
City
Brooksville
State/Province
Florida
ZIP/Postal Code
34601
Country
United States
Facility Name
Research Site 1050
City
Panama City
State/Province
Florida
ZIP/Postal Code
32401
Country
United States
Facility Name
Research Site 1099
City
Port Charlotte
State/Province
Florida
ZIP/Postal Code
33952
Country
United States
Facility Name
Research Site 1066
City
Tampa
State/Province
Florida
ZIP/Postal Code
33634
Country
United States
Facility Name
Research Site 1072
City
Augusta
State/Province
Georgia
ZIP/Postal Code
30909
Country
United States
Facility Name
Research Site 1082
City
Pocatello
State/Province
Idaho
ZIP/Postal Code
83201
Country
United States
Facility Name
Research Site 1258
City
Champaign
State/Province
Illinois
ZIP/Postal Code
61822
Country
United States
Facility Name
Research Site 1043
City
Anderson
State/Province
Indiana
ZIP/Postal Code
46011
Country
United States
Facility Name
Research Site 1071
City
Avon
State/Province
Indiana
ZIP/Postal Code
46123
Country
United States
Facility Name
Research Site 1086
City
Des Moines
State/Province
Iowa
ZIP/Postal Code
50314
Country
United States
Facility Name
Research Site 1224
City
Covington
State/Province
Kentucky
ZIP/Postal Code
41011
Country
United States
Facility Name
Research Site 1228
City
Annapolis
State/Province
Maryland
ZIP/Postal Code
21401
Country
United States
Facility Name
Research Site 1221
City
Baltimore
State/Province
Maryland
ZIP/Postal Code
21202
Country
United States
Facility Name
Research Site 1079
City
Hyattsville
State/Province
Maryland
ZIP/Postal Code
20782
Country
United States
Facility Name
Research Site 1223
City
Midland
State/Province
Michigan
ZIP/Postal Code
48670
Country
United States
Facility Name
Research Site 1217
City
Petoskey
State/Province
Michigan
ZIP/Postal Code
49770
Country
United States
Facility Name
Research Site 1254
City
Ypsilanti
State/Province
Michigan
ZIP/Postal Code
48197
Country
United States
Facility Name
Research Site 1054
City
Saint Louis
State/Province
Missouri
ZIP/Postal Code
63136
Country
United States
Facility Name
Research Site 1060
City
Saint Louis
State/Province
Missouri
ZIP/Postal Code
63141
Country
United States
Facility Name
Research Site 1252
City
Kalispell
State/Province
Montana
ZIP/Postal Code
59901
Country
United States
Facility Name
Research Site 1052
City
Omaha
State/Province
Nebraska
ZIP/Postal Code
68131
Country
United States
Facility Name
Research Site 1263
City
Omaha
State/Province
Nebraska
ZIP/Postal Code
68198
Country
United States
Facility Name
Research Site 1080
City
Las Vegas
State/Province
Nevada
ZIP/Postal Code
89123
Country
United States
Facility Name
Research Site 1219
City
Somerset
State/Province
New Jersey
ZIP/Postal Code
08873
Country
United States
Facility Name
Research Site 1044
City
Albuquerque
State/Province
New Mexico
ZIP/Postal Code
87102
Country
United States
Facility Name
Research Site 1264
City
Bronx
State/Province
New York
ZIP/Postal Code
10468
Country
United States
Facility Name
Research Site 1220
City
Saratoga Springs
State/Province
New York
ZIP/Postal Code
12866
Country
United States
Facility Name
Research Site 1049
City
West Seneca
State/Province
New York
ZIP/Postal Code
14224
Country
United States
Facility Name
Research Site 1085
City
Chapel Hill
State/Province
North Carolina
ZIP/Postal Code
27517
Country
United States
Facility Name
Research Site 1074
City
Charlotte
State/Province
North Carolina
ZIP/Postal Code
28204
Country
United States
Facility Name
Research Site 1056
City
Morehead City
State/Province
North Carolina
ZIP/Postal Code
28557
Country
United States
Facility Name
Research Site 1229
City
Wilmington
State/Province
North Carolina
ZIP/Postal Code
28401
Country
United States
Facility Name
Research Site 1064
City
Winston-Salem
State/Province
North Carolina
ZIP/Postal Code
27103
Country
United States
Facility Name
Research Site 1075
City
Fargo
State/Province
North Dakota
ZIP/Postal Code
58103
Country
United States
Facility Name
Research Site 1266
City
Lindsay
State/Province
Oklahoma
ZIP/Postal Code
73052
Country
United States
Facility Name
Research Site 1055
City
Oklahoma City
State/Province
Oklahoma
ZIP/Postal Code
73119
Country
United States
Facility Name
Research Site 1265
City
Oklahoma City
State/Province
Oklahoma
ZIP/Postal Code
73134
Country
United States
Facility Name
Research Site 1046
City
Oklahoma City
State/Province
Oklahoma
ZIP/Postal Code
73135
Country
United States
Facility Name
Research Site 1260
City
Lancaster
State/Province
Pennsylvania
ZIP/Postal Code
17601
Country
United States
Facility Name
Research Site 1042
City
Cumberland
State/Province
Rhode Island
ZIP/Postal Code
02864
Country
United States
Facility Name
Research Site 1225
City
Austin
State/Province
Texas
ZIP/Postal Code
78758
Country
United States
Facility Name
Research Site 1259
City
Dallas
State/Province
Texas
ZIP/Postal Code
75235
Country
United States
Facility Name
Research Site 1048
City
Kingwood
State/Province
Texas
ZIP/Postal Code
77339
Country
United States
Facility Name
Research Site 1070
City
Lampasas
State/Province
Texas
ZIP/Postal Code
76550
Country
United States
Facility Name
Research Site 1222
City
Lewisville
State/Province
Texas
ZIP/Postal Code
75067
Country
United States
Facility Name
Research Site 1081
City
North Richland Hills
State/Province
Texas
ZIP/Postal Code
76180
Country
United States
Facility Name
Research Site 1226
City
San Antonio
State/Province
Texas
ZIP/Postal Code
78212
Country
United States
Facility Name
Research Site 1053
City
San Antonio
State/Province
Texas
ZIP/Postal Code
78218
Country
United States
Facility Name
Research Site 1063
City
Salt Lake City
State/Province
Utah
ZIP/Postal Code
84124
Country
United States
Facility Name
Research Site 1230
City
Salem
State/Province
Virginia
ZIP/Postal Code
24153
Country
United States
Facility Name
Research Site 5013
City
Vancouver
State/Province
British Columbia
ZIP/Postal Code
V5Z1M9
Country
Canada
Facility Name
Research Site 5015
City
Cambridge
State/Province
Ontario
ZIP/Postal Code
N1R 6V6
Country
Canada
Facility Name
Research Site 5012
City
Hamilton
State/Province
Ontario
ZIP/Postal Code
L8L5G8
Country
Canada
Facility Name
Research Site 5023
City
London
State/Province
Ontario
ZIP/Postal Code
N6A 4V2
Country
Canada
Facility Name
Research Site 5016
City
Peterborough
State/Province
Ontario
ZIP/Postal Code
K9J 0B2
Country
Canada
Facility Name
Research Site 5005
City
Sudbury
State/Province
Ontario
ZIP/Postal Code
P3C 5K7
Country
Canada
Facility Name
Research Site 5022
City
Toronto
State/Province
Ontario
ZIP/Postal Code
M5B 1W8
Country
Canada
Facility Name
Research Site 5014
City
Toronto
State/Province
Ontario
ZIP/Postal Code
M5G 1XS
Country
Canada
Facility Name
Research Site 5008
City
Gatineau
State/Province
Quebec
ZIP/Postal Code
J8Y 6S8
Country
Canada
Facility Name
Research Site 5007
City
St-Charles-Borromee
State/Province
Quebec
ZIP/Postal Code
J6E 6J2
Country
Canada
Facility Name
Research Site 5009
City
St. Georges
State/Province
Quebec
ZIP/Postal Code
G5Y4T8
Country
Canada
Facility Name
Research Site 5006
City
Quebec
ZIP/Postal Code
G1V 4G5
Country
Canada
Facility Name
Research Site 3116
City
Benesov
ZIP/Postal Code
256 01
Country
Czechia
Facility Name
Research Site 3106
City
Brandys nad Labem
ZIP/Postal Code
250 01
Country
Czechia
Facility Name
Research Site 3107
City
Brno
ZIP/Postal Code
60200
Country
Czechia
Facility Name
Research Site 3118
City
Brno
ZIP/Postal Code
639 00
Country
Czechia
Facility Name
Research Site 3109
City
Cesky Krumlov
ZIP/Postal Code
381 01
Country
Czechia
Facility Name
Research Site 3114
City
Havirov
ZIP/Postal Code
736 01
Country
Czechia
Facility Name
Research Site 3103
City
Hradec Kralove
ZIP/Postal Code
50005
Country
Czechia
Facility Name
Research Site 3110
City
Krnov
ZIP/Postal Code
794 01
Country
Czechia
Facility Name
Research Site 3102
City
Kromeriz
ZIP/Postal Code
767 01
Country
Czechia
Facility Name
Research Site 3105
City
Marianske Lazne
ZIP/Postal Code
353 01
Country
Czechia
Facility Name
Research Site 3113
City
Plzen
ZIP/Postal Code
326 00
Country
Czechia
Facility Name
Research Site 3104
City
Praha
ZIP/Postal Code
128 08
Country
Czechia
Facility Name
Research Site 3111
City
Praha
ZIP/Postal Code
149 00
Country
Czechia
Facility Name
Research Site 3112
City
Praha
ZIP/Postal Code
181 00
Country
Czechia
Facility Name
Research Site 3115
City
Uherske Hradiste
ZIP/Postal Code
686 68
Country
Czechia
Facility Name
Research Site 6104
City
Copenhagen
ZIP/Postal Code
2100
Country
Denmark
Facility Name
Research Site 6103
City
Copenhagen
ZIP/Postal Code
2300S
Country
Denmark
Facility Name
Research Site 6105
City
Copenhagen
ZIP/Postal Code
2400
Country
Denmark
Facility Name
Research Site 7007
City
Chuncheon
State/Province
Gangwon-Do
ZIP/Postal Code
200-722
Country
Korea, Republic of
Facility Name
Research Site 7001
City
Wonju
State/Province
Gangwon-Do
ZIP/Postal Code
220-701
Country
Korea, Republic of
Facility Name
Research Site 7004
City
Anyang
State/Province
Gyeonggi-do
ZIP/Postal Code
431-070
Country
Korea, Republic of
Facility Name
Research Site 7005
City
Guri
State/Province
Gyeonggi-do
ZIP/Postal Code
471-701
Country
Korea, Republic of
Facility Name
Research Site 7006
City
Busan
ZIP/Postal Code
602-739
Country
Korea, Republic of
Facility Name
Research Site 7002
City
Gwangju
ZIP/Postal Code
501-757
Country
Korea, Republic of
Facility Name
Research Site 7008
City
Incheon
ZIP/Postal Code
400-711
Country
Korea, Republic of
Facility Name
Research Site 2015
City
Guadalajara
State/Province
Jalisco
ZIP/Postal Code
44160
Country
Mexico
Facility Name
Research Site 2013
City
Culiacan
State/Province
Sinaloa
ZIP/Postal Code
80230
Country
Mexico
Facility Name
Research Site 2008
City
Tampico
State/Province
Tamaulipas
ZIP/Postal Code
89000
Country
Mexico
Facility Name
Research Site 2012
City
Merida
State/Province
Yucatan
ZIP/Postal Code
97218
Country
Mexico
Facility Name
Research Site 2011
City
Aguascalientes
ZIP/Postal Code
20230
Country
Mexico
Facility Name
Research Site 2009
City
Chihuahua
ZIP/Postal Code
31217
Country
Mexico
Facility Name
Research Site 2014
City
Mexico
ZIP/Postal Code
80230
Country
Mexico
Facility Name
Research Site 2016
City
Queretaro
Country
Mexico
Facility Name
Research Site 2010
City
Veracruz
ZIP/Postal Code
91910
Country
Mexico
Facility Name
Research Site 5110
City
Amsterdam
ZIP/Postal Code
2545CH
Country
Netherlands
Facility Name
Research Site 5113
City
Harderwijk
ZIP/Postal Code
3844DG
Country
Netherlands
Facility Name
Research Site 5101
City
Hertogenbosch
ZIP/Postal Code
5223GZ
Country
Netherlands
Facility Name
Research Site 5112
City
Hoofddorp
Country
Netherlands
Facility Name
Research Site 5102
City
Hoogeveen
ZIP/Postal Code
7909AA
Country
Netherlands
Facility Name
Research Site 5106
City
Rotterdam
ZIP/Postal Code
3O45 PM
Country
Netherlands
Facility Name
Research Site 5103
City
Zwijndrecht
ZIP/Postal Code
3331EV
Country
Netherlands
Facility Name
Research Site 7122
City
Aleksandrow Lodzki
ZIP/Postal Code
95-070
Country
Poland
Facility Name
Research Site 7113
City
Gdansk
ZIP/Postal Code
80-126
Country
Poland
Facility Name
Research Site 7119
City
Gdynia
ZIP/Postal Code
81-338
Country
Poland
Facility Name
Research Site 7109
City
Grodzisk Mazowiecki
ZIP/Postal Code
05-825
Country
Poland
Facility Name
Research Site 7115
City
Katowice
ZIP/Postal Code
20-060
Country
Poland
Facility Name
Research Site 7106
City
Katowice
ZIP/Postal Code
40-752
Country
Poland
Facility Name
Research Site 7121
City
Katowice
ZIP/Postal Code
40-954
Country
Poland
Facility Name
Research Site 7111
City
Kutno
ZIP/Postal Code
99-300
Country
Poland
Facility Name
Research Site 7104
City
Lodz
ZIP/Postal Code
90-368
Country
Poland
Facility Name
Research Site 7135
City
Lodz
ZIP/Postal Code
94-255
Country
Poland
Facility Name
Research Site 7120
City
Lublin
ZIP/Postal Code
20-362
Country
Poland
Facility Name
Research Site 7108
City
Olawa
ZIP/Postal Code
55-200
Country
Poland
Facility Name
Research Site 7118
City
Otwock
ZIP/Postal Code
05-402
Country
Poland
Facility Name
Research Site 7107
City
Pulawy
ZIP/Postal Code
24-100
Country
Poland
Facility Name
Research Site 7105
City
Sobotka
ZIP/Postal Code
55-050
Country
Poland
Facility Name
Research Site 7112
City
Sochaczew
ZIP/Postal Code
96-500
Country
Poland
Facility Name
Research Site 7123
City
Warsaw
ZIP/Postal Code
00-465
Country
Poland
Facility Name
Research Site 7117
City
Warszawa
ZIP/Postal Code
01-868
Country
Poland
Facility Name
Research Site 7116
City
Warszawa
ZIP/Postal Code
04-730
Country
Poland
Facility Name
Research Site 9309
City
Lomonosov
Country
Russian Federation
Facility Name
Research Site 9303
City
Moscow
Country
Russian Federation
Facility Name
Research Site 9315
City
Moscow
Country
Russian Federation
Facility Name
Research Site 9314
City
Novosibirsk
ZIP/Postal Code
630099
Country
Russian Federation
Facility Name
Research Site 9318
City
Novosibirsk
ZIP/Postal Code
630099
Country
Russian Federation
Facility Name
Research Site 9301
City
Novosibirsk
Country
Russian Federation
Facility Name
Research Site 9310
City
Saint Petersburg
ZIP/Postal Code
1199044
Country
Russian Federation
Facility Name
Research Site 9304
City
Saint Petersburg
Country
Russian Federation
Facility Name
Research Site 9307
City
Saint Petersburg
Country
Russian Federation
Facility Name
Research Site 9311
City
Saint Petersburg
Country
Russian Federation
Facility Name
Research Site 9312
City
Saint Petersburg
Country
Russian Federation
Facility Name
Research Site 9302
City
Tomsk
ZIP/Postal Code
6340
Country
Russian Federation
Facility Name
Research Site 8001
City
Kaohsiung
ZIP/Postal Code
807
Country
Taiwan
Facility Name
Research Site 8002
City
New Taipei
ZIP/Postal Code
231
Country
Taiwan
Facility Name
Research Site 8006
City
Taichung
ZIP/Postal Code
404
Country
Taiwan
Facility Name
Research Site 8005
City
Tainan
ZIP/Postal Code
704
Country
Taiwan
Facility Name
Research Site 8007
City
Taipei
ZIP/Postal Code
100
Country
Taiwan
Facility Name
Research Site 8004
City
Taipei
ZIP/Postal Code
111
Country
Taiwan
Facility Name
Research Site 8003
City
Taipei
ZIP/Postal Code
112
Country
Taiwan

12. IPD Sharing Statement

Plan to Share IPD
No

Learn more about this trial

Bexagliflozin Efficacy and Safety Trial

We'll reach out to this number within 24 hrs